SFOSF News and Press, Shanghai Fosun Pharmaceutical Co. Ltd.

2024-03-08 05:20:00 ET Summary Fosun International is reportedly looking to sell some or all of its tourism unit’s Atlantis Sanya mega-resort, as well as a stake in the unit’s Club Med resort chain. The conglomerate Fosun International is doing this to raise cash to ...

2023-12-17 02:00:00 ET Summary SystImmune out-licenses global rights for a bispecific ADC to Bristol Myers Squibb in an $8.4 billion agreement. Evive Biotech forms an antibody discovery collaboration with Nona Biosciences to accelerate the process of antibody discovery and drug de...

2023-09-07 04:06:00 ET Summary Income from new and innovative drugs boosted the Fosun's core pharmaceutical business, where revenues rose nearly 12% to 15.92 billion yuan. But Fosun Pharma carries a heavy debt burden with 27.53 billion yuan of external guarantees. The drugmake...

2023-08-30 11:42:12 ET More on Shanghai Fosun Pharmaceutical Syneos, Fosun Pharma team up to launch lung cancer drug serplulimab in US BioNTech, Fosun Omicron-adapted booster gets approval in Hong Kong for aged 12 and above Sirona, Wanbang expand collaboration on TFC...

2023-06-11 08:30:00 ET Summary Shenzhen HighTide Therapeutics filed for an IPO on the Hong Kong Exchange to develop a portfolio of novel multifunctional drugs for metabolic and digestive diseases. Shanghai Fosun Pharma will partner with World Bank affiliate International Finance C...

2023-05-09 11:29:00 ET Summary Fosun Pharma’s revenue grew slightly in the first quarter on its diverse product portfolio, while its net profit soared by 116%. CanSino’s revenue plunged 80% in the same three-month period, and it swung to the red on heavy marketing an...

2023-04-04 10:00:00 ET Summary Fosun Pharma’s net profit fell more than 20% last year due to a 30% drop in sales of its Comirnaty Covid vaccine and investment losses. The company’s innovative drugs generated more than 10 billion yuan during the year. Fosun Pharma...

Summary Fosun Pharma said it sold 1.09 million BioNTech shares for $179 million, generating big profits after the stock rose more than fivefold from the original purchase price. Fosun Pharma said the sale won’t affect the two companies’ business alliance, which inclu...

Summary CBC Healthcare Infrastructure Platform announced plans to build a $137 million biopharma center in Western Shanghai. Eucure Biopharma, a Beijing antibody company, will collaborate with Korea’s ISU ABXIS. China has agreed to let Germany's BioNTech bring its COVID...

Summary Fosun has sold down its stake in New China Life, its latest move to raise cash as it faces large debt maturing in the next 12 months. The company is also selling down stakes in its Fosun Tourism unit, owner of the Club Med resort chain, and appears to be selling shares in ...